Wilk, an Israeli food tech company, secured USD 3.5 million in a strategic investment round led by Danone Manifesto Ventures. The investment also saw participation from Steakholder Meat and Central Bottling Co Ltd, the owner of the Coca-Cola franchise in Israel.

Danone invested USD 2 million of the total amount of funding for a minimum of 2% of Wilk’s share capital and intends to collaborate with Wilk to develop cultured breast milk components for infant formula.

Steakholder Foods plans to buy ordinary shares of Wilk with a 2.5% stake valued at USD 450,000. This investment will be closed at a 15% discount on the 45-day average closing price of the shares. The company aims to establish synergies with Wilk, working on strategic collaborations in cultured milk biology and printing technologies.

Analyst QuickTake : Wilk is the world’s first publicly listed cell-cultured milk company. It received US patent approval in February 2022 for cell-based milk production and in June 2022, successfully produced the breast milk protein, lactoferrin , vital for the growth and development of infants.